Childhood-onset progressive dystonia associated with pathogenic truncating variants in CHD8.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
10 2021
Historique:
revised: 06 08 2021
received: 02 07 2021
accepted: 06 08 2021
pubmed: 21 8 2021
medline: 26 2 2022
entrez: 20 8 2021
Statut: ppublish

Résumé

Originally described as a risk factor for autism, CHD8 loss-of-function variants have recently been associated with a wider spectrum of neurodevelopmental abnormalities. We further expand the CHD8-related phenotype with the description of two unrelated patients who presented with childhood-onset progressive dystonia. Whole-exome sequencing conducted in two independent laboratories revealed a CHD8 nonsense variant in one patient and a frameshift variant in the second. The patients had strongly overlapping phenotypes characterized by generalized dystonia with mild-to-moderate neurodevelopmental comorbidity. Deep brain stimulation led to clinical improvement in both cases. We suggest that CHD8 should be added to the growing list of neurodevelopmental disorder-associated genes whose mutations can also result in dystonia-dominant phenotypes.

Identifiants

pubmed: 34415117
doi: 10.1002/acn3.51444
pmc: PMC8528468
doi:

Substances chimiques

CHD8 protein, human 0
DNA-Binding Proteins 0
Transcription Factors 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1986-1990

Informations de copyright

© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Mol Cell Biol. 2008 Jun;28(12):3894-904
pubmed: 18378692
Am J Hum Genet. 2021 Mar 4;108(3):530-531
pubmed: 33667397
Mov Disord. 2018 Apr;33(4):656-657
pubmed: 29436745
Lancet Neurol. 2020 Nov;19(11):908-918
pubmed: 33098801
Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):557-564
pubmed: 31721432
Mov Disord. 2021 Jun;36(6):1461-1462
pubmed: 33638881
Clin Genet. 2019 Jul;96(1):72-84
pubmed: 31001818
Cell. 2014 Jul 17;158(2):263-276
pubmed: 24998929
Can J Neurol Sci. 2021 May;48(3):433-434
pubmed: 32959737
Brain. 2020 Dec 5;143(11):3242-3261
pubmed: 33150406
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868

Auteurs

Diane Doummar (D)

Pediatric Neurology Department, Movement Disorders Center, Armand Trousseau Hospital, AP-HP.Sorbonne Université, Paris, France.

Marco Treven (M)

Department of Neurology, Medical University of Vienna, Vienna, Austria.
Konrad Lorenz Institute for Evolution and Cognition Research, Klosterneuburg, 3400, Austria.

Leila Qebibo (L)

Cerebellar Malformations and Congenital diseases Reference Center and Neurogenetics Lab, Department of Genetics, Armand Trousseau Hospital, AP-HP.Sorbonne Université, Paris, France.

David Devos (D)

Université de Lille, INSERM, U1172, CHU-Lille, Lille, France.
Neuroscience Cognition Research Centre, Lille, France.
Neurology and Movement Disorders Department, CHU Lille, Licend, Lille, 59000, France.

Jamal Ghoumid (J)

CHU Lille, University of Lille, ULR7364 RADEME, Lille, France.

Claudia Ravelli (C)

Pediatric Neurology Department, Movement Disorders Center, Armand Trousseau Hospital, AP-HP.Sorbonne Université, Paris, France.

Gottfried Kranz (G)

Neurorehabilitationszentrum Rosenhügel, Vienna, Austria.

Martin Krenn (M)

Department of Neurology, Medical University of Vienna, Vienna, Austria.
School of Medicine, Institute of Human Genetics, Technical University of Munich, Munich, Germany.

Diane Demailly (D)

Département de Neurochirurgie, Unité des Pathologies Cérébrales Résistantes, Unité de Recherche sur les Comportements et Mouvements Anormaux, Hôpital Gui de Chauliac, Centre Hospitalier Régional Montpellier, Montpellier, France.
Faculté de médecine, Université de Montpellier, France.

Laura Cif (L)

Département de Neurochirurgie, Unité des Pathologies Cérébrales Résistantes, Unité de Recherche sur les Comportements et Mouvements Anormaux, Hôpital Gui de Chauliac, Centre Hospitalier Régional Montpellier, Montpellier, France.
Faculté de médecine, Université de Montpellier, France.

Jean-Baptiste Davion (JB)

Service de Neurologie pédiatrique, CHU Lille, Lille, 59000, France.

Fritz Zimprich (F)

Department of Neurology, Medical University of Vienna, Vienna, Austria.

Lydie Burglen (L)

Cerebellar Malformations and Congenital diseases Reference Center and Neurogenetics Lab, Department of Genetics, Armand Trousseau Hospital, AP-HP.Sorbonne Université, Paris, France.
Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris, France.

Michael Zech (M)

School of Medicine, Institute of Human Genetics, Technical University of Munich, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH